Shares of biotech firm Geron fall 70% after Johnson & Johnson ends collaboration

The two companies had been working together on a cancer since 2014.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.